valproic acid has been researched along with acid phosphatase in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellringer, ME; Coleman, R; Rahman, K | 1 |
| Chaturvedi, NK; Chou, YW; Kaushik, D; Kim, I; Lin, FF; Lin, MF; Ouyang, S; Wang, J | 1 |
| Anwar, MJ; Radhakrishna, KV; Vohora, D | 1 |
3 other study(ies) available for valproic acid and acid phosphatase
| Article | Year |
|---|---|
Sodium valproate inhibits the movement of secretory vesicles in rat hepatocytes.
Topics: Acid Phosphatase; Animals; Bile; Biliary Fistula; Caprylates; Cytoplasmic Granules; Immunoglobulin A; Liver; Male; Perfusion; Phospholipids; Rats; Rats, Inbred Strains; Serum Albumin; Triglycerides; Valproic Acid | 1988 |
Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells.
Topics: Acid Phosphatase; Antineoplastic Agents; Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Separation; Flow Cytometry; Histone Deacetylase Inhibitors; Humans; Male; Phosphorylation; Prostatic Neoplasms; Protein Tyrosine Phosphatases; Receptor, ErbB-2; Valproic Acid | 2011 |
Phenytoin and sodium valproate but not levetiracetam induce bone alterations in female mice.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Anticonvulsants; Biomarkers; Bone Density; Calcium; Female; Hydroxyproline; Isoenzymes; Levetiracetam; Lumbar Vertebrae; Mice; Phenytoin; Piracetam; Tartrate-Resistant Acid Phosphatase; Valproic Acid | 2014 |